Get the Stockscreener App
0.00
100.00%
-0.50
Tc Biopharm Holdings Plc Adr Stock (TCBP) Forecast
The Tc Biopharm Holdings Plc Adr (TCBP) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $629.76, representing a + increase from the current price of $0.00. The highest analyst price target is $645.72, and the lowest is $613.79.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TCBP Price Target
Average 445.11
(+ Upside)
Is Tc Biopharm Holdings Plc Adr (TCBP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 23.00 | Buy |
| STOCH(9,6) | 17.44 | Buy |
| STOCHRSI(14) | 23.46 | Neutral |
| MACD(12,26) | -0.2139 | Sell |
| ADX(14) | 19.44 | Neutral |
| William %R | -100.00 | Buy |
| CCI(14) | -263.50 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.381
Sell
|
1.2139
Sell
|
| MA20 |
1.667
Sell
|
1.4812
Sell
|
| MA50 |
1.3621
Sell
|
1.4687
Sell
|
| MA100 |
0.9934
Sell
|
1.8216
Sell
|
| MA200 |
3.1276
Sell
|
3.9507
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, TCBP could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on TCBP, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 23 indicates that TCBP is oversold. This indicates that TCBP price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 17.44 indicates that TCBP is oversold. This indicates that TCBP price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 23.46 indicates that TCBP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.44 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -263.5 indicates that TCBP is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term TCBP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Tc Biopharm Holdings Plc Adr financial reports and earnings history, Tc Biopharm Holdings Plc Adr (TCBP) stock could reach $2,468.96 by 2030, $5,335.37 by 2040 and $7,500.72 by 2050. See the projected annual prices until 2050 of the Tc Biopharm Holdings Plc Adr stock below:
- Tc Biopharm Holdings Plc Adr (TCBP) is expected to reach an average price of $3,921.15 in 2035, with a high prediction of $4,096.71 and a low estimate of $3,934.55. This indicates an $ rise from the last recorded price of $0.00.
- Tc Biopharm Holdings Plc Adr (TCBP) stock is projected to chart a bullish course in 2040, with an average price target of $5,215.65, representing an $ surge from its current level. The forecast ranges from a conservative $5,222.05 to a sky-high $5,335.37.
- Our analysts predict Tc Biopharm Holdings Plc Adr (TCBP) to jump by 2045, soaring from $6,306.34 to an average price of $6,304.14, potentially reaching $6,528.11. While $6,306.34 is the low estimate, the potential upside is significant.
- Tc Biopharm Holdings Plc Adr (TCBP) stock is expected to climb by 2050, reaching an average of $7,227.48, a $ jump from its current level. However, a wide range of estimates exists, with high and low targets of $7,500.72 and $7,230.28, respectively, highlighting the market's uncertainty.
Tc Biopharm Holdings Plc Adr Stock (TCBP) Year by Year Forecast
Tc Biopharm Holdings Plc Adr Stock (TCBP) Price Forecast for 2025
Tc Biopharm Holdings Plc Adr Stock (TCBP) is expected to reach an average price of $578.51 in 2025, with a high prediction of $746.52 and a low estimate of $410.51. This indicates an + rise from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $580.79 | $613.79 | $645.72 | + |
| June, 2025 | $630.28 | $623.46 | $619.14 | + |
| July, 2025 | $612.20 | $613.19 | $613.35 | + |
| August, 2025 | $584.69 | $585.08 | $592.02 | + |
| September, 2025 | $545.38 | $546.58 | $569.71 | + |
| October, 2025 | $501.15 | $501.40 | $534.25 | + |
| November, 2025 | $457.99 | $459.59 | $486.92 | + |
| December, 2025 | $409.31 | $410.51 | $440.82 | + |
Tc Biopharm Holdings Plc Adr Stock (TCBP) Price Forecast for 2026
The predicted value for Tc Biopharm Holdings Plc Adr (TCBP) in 2026 is set at an average of $573.56. Estimates vary from a peak of $1,137.09 to a trough of $10.03, indicating an + surge from the present price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $372.52 | $373.00 | $398.73 | + |
| February, 2026 | $333.29 | $333.67 | $361.72 | + |
| March, 2026 | $292.98 | $293.78 | $321.52 | + |
| April, 2026 | $244.48 | $244.49 | $279.81 | + |
| May, 2026 | $208.77 | $208.83 | $235.32 | + |
| June, 2026 | $170.00 | $170.04 | $198.14 | + |
| July, 2026 | $119.94 | $120.16 | $160.01 | + |
| August, 2026 | $79.77 | $79.97 | $109.87 | + |
| September, 2026 | $29.88 | $29.97 | $69.73 | + |
| October, 2026 | $1,337.09 | $10.03 | $1,137.09 | + |
| November, 2026 | $1,267.27 | $1,137.22 | $1,012.18 | + |
| December, 2026 | $1,237.50 | $1,107.41 | $997.32 | + |
Tc Biopharm Holdings Plc Adr Stock (TCBP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Tc Biopharm Holdings Plc Adr (TCBP) is $1,584.77, with a high forecast of $1,878.83 and a low forecast of $1,290.71. This indicates an + increase from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1,887.79 | $1,627.59 | $1,788.69 | + |
| February, 2027 | $1,824.97 | $1,830.87 | $1,878.83 | + |
| March, 2027 | $1,720.10 | $1,767.10 | $1,787.92 | + |
| April, 2027 | $1,690.39 | $1,694.65 | $1,669.54 | + |
| May, 2027 | $1,673.37 | $1,652.83 | $1,658.33 | + |
| June, 2027 | $1,658.13 | $1,658.16 | $1,623.61 | + |
| July, 2027 | $1,597.89 | $1,613.79 | $1,628.65 | + |
| August, 2027 | $1,592.47 | $1,595.07 | $1,603.98 | + |
| September, 2027 | $1,489.70 | $1,509.90 | $1,563.12 | + |
| October, 2027 | $1,385.89 | $1,401.89 | $1,405.44 | + |
| November, 2027 | $1,335.27 | $1,337.47 | $1,349.74 | + |
| December, 2027 | $1,287.91 | $1,290.71 | $1,313.12 | + |
Tc Biopharm Holdings Plc Adr Stock (TCBP) Price Forecast for 2028
In 2028, Tc Biopharm Holdings Plc Adr (TCBP) is projected to reach an average price of $771.85, with a high projection of $1,262.35 and a low estimate of $281.35. This indicates an + rise from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1,217.89 | $1,218.29 | $1,262.35 | + |
| February, 2028 | $1,142.88 | $1,144.68 | $1,193.54 | + |
| March, 2028 | $1,048.23 | $1,049.51 | $1,123.08 | + |
| April, 2028 | $971.59 | $971.89 | $1,027.17 | + |
| May, 2028 | $871.26 | $871.72 | $949.34 | + |
| June, 2028 | $791.11 | $791.63 | $849.23 | + |
| July, 2028 | $713.91 | $714.69 | $769.85 | + |
| August, 2028 | $612.12 | $613.50 | $690.34 | + |
| September, 2028 | $534.35 | $535.31 | $590.18 | + |
| October, 2028 | $459.44 | $459.86 | $513.75 | + |
| November, 2028 | $360.70 | $360.78 | $437.79 | + |
| December, 2028 | $281.23 | $281.35 | $340.86 | + |
Tc Biopharm Holdings Plc Adr Stock (TCBP) Price Forecast for 2029
The 2029 price forecast for Tc Biopharm Holdings Plc Adr Stock (TCBP) is $1,514.59 on average, with a high prediction of $3,007.70 and a low estimate of $21.48. This represents an + increase from the previous price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $180.86 | $181.04 | $260.94 | + |
| February, 2029 | $101.12 | $101.13 | $160.90 | + |
| March, 2029 | $51.36 | $21.48 | $81.23 | + |
| April, 2029 | $2,385.77 | $2,445.77 | $2,405.63 | + |
| May, 2029 | $2,136.11 | $2,306.11 | $2,215.98 | + |
| June, 2029 | $2,772.89 | $2,635.05 | $2,721.89 | + |
| July, 2029 | $2,967.27 | $2,994.27 | $3,007.70 | + |
| August, 2029 | $2,837.02 | $2,843.02 | $2,916.81 | + |
| September, 2029 | $2,727.19 | $2,733.72 | $2,797.09 | + |
| October, 2029 | $2,621.14 | $2,632.04 | $2,688.66 | + |
| November, 2029 | $2,597.42 | $2,607.92 | $2,569.21 | + |
| December, 2029 | $2,530.09 | $2,537.59 | $2,547.99 | + |
Tc Biopharm Holdings Plc Adr Stock (TCBP) Price Forecast for 2030
Tc Biopharm Holdings Plc Adr Stock (TCBP) is expected to reach an average price of $1,801.58 in 2030, with a high forecast of $2,468.96 and a low forecast of $1,134.20. This signifies an + surge from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2,451.74 | $2,460.54 | $2,468.96 | + |
| February, 2030 | $2,351.82 | $2,372.62 | $2,417.64 | + |
| March, 2030 | $2,207.10 | $2,229.29 | $2,208.69 | + |
| April, 2030 | $2,040.37 | $2,073.37 | $2,165.17 | + |
| May, 2030 | $1,966.32 | $1,981.52 | $2,038.81 | + |
| June, 2030 | $1,892.20 | $1,893.19 | $1,937.99 | + |
| July, 2030 | $1,753.94 | $1,756.14 | $1,852.07 | + |
| August, 2030 | $1,636.67 | $1,637.02 | $1,720.41 | + |
| September, 2030 | $1,521.75 | $1,522.00 | $1,606.49 | + |
| October, 2030 | $1,365.65 | $1,369.85 | $1,487.57 | + |
| November, 2030 | $1,250.32 | $1,251.52 | $1,336.34 | + |
| December, 2030 | $1,133.72 | $1,134.20 | $1,219.79 | + |
0.24%
36.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):